A new op-ed published in the Wall Street Journal explores myths about the rate of drug inflation and discusses how policymakers can keep prescription drugs affordable for patients while encouraging medical innovation. The piece was written by Dana Goldman, PhD, and Erin Trish, PhD, who are co-directors of the USC Schaeffer Center.

To read the article on the USC School of Pharmacy site, click here.